Dark

TENX
Tenax Therapeutics, Inc.
stock NASDAQ

Feb 11, 2026

12.99USD+1.564%(+0.20)150,558

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

81.17M

CEO

Anthony DiTonno

Headquarters

Morrisville, North Carolina, USA

Industry

Biotechnology

Next Earnings

Mar 24, 2026 (39d)

Last Split

Jan 3, 20241for80reverse

XLV

TENX Stats

Avg. Vol. 10 Day

190,644

Avg. Vol. 30 Day

287,377

Market Cap

81,166,475

Shares Out.

6,243,575

On/Off Exchange

53%/47%

6 Month Beta

0.35

1 Year Beta

0.22

2 Year Beta

0.46

3 Year Beta

0.34

52 Week Low

4.63

52 Week High

18.38

SMA50

12.55

SMA200

7.93

1 Week

-0.99%

1 Month

-11.57%

3 Month

+84.66%

6 Month

+122.22%

1 Year

+76.63%

2 Year

+169.15%

5 Year

-99.71%

Profile

tenax therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions. our development portfolio includes novel product candidates that have the potential to address various critical care conditions with high unmet medical need.

TENX Stock Summary

Tenax Therapeutics, Inc. (NASDAQ:TENX) stock price today is $12.99, and today's volume is 150,558. TENX is up 1.564% today. The 30 day average volume is 287,377. TENX market cap is 81.17M with 6,243,575 shares outstanding.

.dark-mode .KGDB4y{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .KGDB4y{ color: #333333; background-color: white; border: 2px solid #333333; }TENXTenax Therapeutics, Inc.stock NASDAQ

TENX Stock Summary

TENX
Tenax Therapeutics, Inc.
stock NASDAQ